A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma

References

• Villanueva A . Hepatocellular carcinoma. N Engl J Med . 2019;381(1):e2. doi:10.1056/NEJMc1906565
   PubMed Web of Science ®Google Scholar
• Yan Y , Zheng L , Du Q , et al. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC). Cancer Lett . 2021;506:95–106. doi:10.1016/j.canlet.2021.03.002 33689775
   PubMed Web of Science ®Google Scholar
• Yang S , Jiang W , Yang W , et al. Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway. Mol Ther Nucleic Acids . 2021;23:944–958. doi:10.1016/j.omtn.2021.01.008 33614242
   PubMedGoogle Scholar
• Shigesawa T , Maehara O , Suda G , et al. Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling. Carcinogenesis . 2021;42(1):58–69. doi:10.1093/carcin/bgaa049 32449510
   PubMed Web of Science ®Google Scholar
• Zhang J , Chen G , Zhang J , et al. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC). Am J Transl Res . 2020;12(9):5108–5130.33042409
   PubMed Web of Science ®Google Scholar
• Hu X , Wang X , Jia F , et al. A trans-fatty acid-rich diet promotes liver tumorigenesis in HCV core gene transgenic mice. Carcinogenesis . 2020;41(2):159–170. doi:10.1093/carcin/bgz132 31300810
   PubMed Web of Science ®Google Scholar
• Kang Q , Chen J , Luo H , et al. Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication. Dis Markers . 2020;2020:8539804. doi:10.1155/2020/8539804 33082884
   PubMed Web of Science ®Google Scholar
• Xie M , Guo H , Lou G , et al. Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1α-C/EBPα- HNF4α axis. J Cell Mol Med . 2021;25(2):840–854. doi:10.1111/jcmm.16137 33263949
   PubMed Web of Science ®Google Scholar
• Zhao B , Ke K , Wang Y , et al. HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis. Signal Transduct Target Ther . 2020;5(1):118. doi:10.1038/s41392-020-00223-6 32636357
   PubMed Web of Science ®Google Scholar
• Bray F , Ferlay J , Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2018;68(6):394–424.30207593
   PubMed Web of Science ®Google Scholar
• Bae SDW , Nguyen R , Qiao L , et al. Role of the constitutive androstane receptor (CAR) in human liver cancer. Biochim Biophys Acta Rev Cancer . 2021;1875(2):188516. doi:10.1016/j.bbcan.2021.188516 33529650
   PubMed Web of Science ®Google Scholar
• Han R , Nusbaum O , Chen X , et al. Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor. Mol Ther Oncolytics . 2020;19:8–18. doi:10.1016/j.omto.2020.08.017 33024815
   PubMed Web of Science ®Google Scholar
• Jiao Y , Xu P , Shi H , et al. Advances on liver cell-derived exosomes in liver diseases. J Cell Mol Med . 2021;25(1):15–26. doi:10.1111/jcmm.16123 33247543
   PubMed Web of Science ®Google Scholar
• Ahodantin J , Lekbaby B , Bou Nader M , et al. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells. Carcinogenesis . 2020;41(3):358–367. doi:10.1093/carcin/bgz109 31175830
   PubMed Web of Science ®Google Scholar
• Nasr MM , Nasr MM , Shehata LH . Clinical oncology research; Review on contemporary methodology standards. Curr Probl Cancer . 2021;100725. doi:10.1016/j.currproblcancer.2021.100725 33715867
   PubMed Web of Science ®Google Scholar
• Khan P , Siddiqui JA , Lakshmanan I , et al. RNA-based therapies: a cog in the wheel of lung cancer defense. Mol Cancer . 2021;20(1):54. doi:10.1186/s12943-021-01338-2 33740988
   PubMed Web of Science ®Google Scholar
• Brachtlova T , van Ginkel JW , Luinenburg MJ , et al. Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format. Mol Ther Oncolytics . 2020;19:332–343. doi:10.1016/j.omto.2020 33335978
   PubMed Web of Science ®Google Scholar
• Huang X , Zhu X , Yu Y , et al. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett . 2021;501:66–82. doi:10.1016/j.canlet.2020.12.025 33385486
   PubMed Web of Science ®Google Scholar
• Hou J , Lin L , Zhou W , et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell . 2011;19:232–243. doi:10.1016/j.ccr.2011.01.001 21316602
   PubMed Web of Science ®Google Scholar
• Cai M , Shao W , Yu H , et al. Paeonol Inhibits Cell Proliferation, Migration and Invasion and Induces Apoptosis in Hepatocellular Carcinoma by Regulating miR-21-5p/KLF6 Axis. Cancer Manag Res . 2020;12:5931–5943. doi:10.2147/CMAR.S254485 32765094
   PubMed Web of Science ®Google Scholar
• Huang DP , Zeng YH , Yuan WQ , et al. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma. Int J Med Sci . 2021;18(2):335–346. doi:10.7150/ijms.50126 33390802
   PubMed Web of Science ®Google Scholar
• Chen J , Ding C , Chen Y , et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Lett . 2021;502:154–165. doi:10.1016/j.canlet.2020.12.019 33340617
   PubMed Web of Science ®Google Scholar
• Wang C , Zhang J , Yin J , et al. Alternative approaches to target Myc for cancer treatment. Signal Transduct Target Ther . 2021;6(1):117. doi:10.1038/s41392-021-00500-y 33692331
   PubMed Web of Science ®Google Scholar
• Freimuth J , Gassler N , Moro N , et al. Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma. Mol Cancer . 2010;9:94. doi:10.1186/1476-4598-9-94 20429921
   PubMed Web of Science ®Google Scholar
• Uhlen M , Zhang C , Lee S , et al. A pathology atlas of the human cancer transcriptome. Science . 2017;357(6352):eaan2507. doi:10.1126/science.aan2507 28818916
   PubMed Web of Science ®Google Scholar
• Pontén F , Jirström K , Uhlen M . The Human Protein Atlas--a tool for pathology. J Pathol . 2008;216(4):387–393. doi:10.1002/path.2440 18853439
   PubMed Web of Science ®Google Scholar
• Chen C , Chen H , Zhang Y , et al. TBtools: an Integrative Toolkit Developed for Interactive Analyses of Big Biological Data. Mol Plant . 2020;13(8):1194–1202. doi:10.1016/j.molp.2020.06.009 32585190
   PubMed Web of Science ®Google Scholar
• Shi Y , Zhang DD , Liu JB , et al. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Mol Ther Nucleic Acids . 2021;23:702–718. doi:10.1016/j.omtn.2020.12.016 33575116
   PubMedGoogle Scholar
• Koch A , De Meyer T , Jeschke J , et al. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics . 2015;16(1):636. doi:10.1186/s12864-015-1847-z 26306699
   PubMed Web of Science ®Google Scholar
• Cerami E , Gao J , Dogrusoz U . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov . 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-0095 22588877
   PubMed Web of Science ®Google Scholar
• Gao J , Aksoy BA , Dogrusoz U , et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal . 2013;6(269):pl1. doi:10.1126/scisignal.2004088 23550210
   PubMed Web of Science ®Google Scholar
• Li T , Fan J , Wang B , et al. TIMER: a Web Server for Comprehensive Analysis of Tumor-Infiltrating ImmuneCells. Cancer Res . 2017;77(21):e108–10. doi:10.1158/0008-5472.CAN-17-0307 29092952
   PubMed Web of Science ®Google Scholar
• Li B , Li T , Liu JS , Liu XS . Computational Deconvolution of Tumor-Infiltrating Immune Components with Bulk Tumor Gene Expression Data. Methods Mol Biol . 2020;2120:249–262. doi:10.1007/978-1-0716-0327-7_18 32124325
   PubMedGoogle Scholar
• Hu Y , Zhang X , Zai HY , et al. lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1. Mol Ther Oncolytics . 2020;19:308–322. doi:10.1016/j.omto.2020.10.010 33313387
   PubMed Web of Science ®Google Scholar
• Ma S , Cheng J , Wang H , et al. A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells. Carcinogenesis . 2021;42(1):93–104. doi:10.1093/carcin/bgaa055 32531042
   PubMed Web of Science ®Google Scholar
• Jiang X , Xing L , Chen Y , et al. CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells. Mol Ther Nucleic Acids . 2020;23:310–323. doi:10.1016/j.omtn.2020.11.009 33425489
   PubMedGoogle Scholar
• Guo H , Xu J , Zheng Q , et al. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis. Cancer Lett . 2019;466:39–48. doi:10.1016/j.canlet.2019.09.010 31546024
   PubMed Web of Science ®Google Scholar
• Dalwadi DA , Torrens L , Abril-Fornaguera J , et al. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Mol Ther . 2021;29(2):680–690. doi:10.1016/j.ymthe.2020.10.018 33554867
   PubMed Web of Science ®Google Scholar
• Zhang JJ , Hong J , Ma YS , et al. Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression. Dis Markers . 2021;2021:6696198. doi:10.1155/2021/6696198 33505535
   PubMed Web of Science ®Google Scholar
• Tian LL , Qian B , Jiang XH , et al. MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients. Int J Genomics . 2021;2021:6670390. doi:10.1155/2021/6670390 33816607
   PubMed Web of Science ®Google Scholar
• Li W , Liu Y , Li ZJ , et al. Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma. Biomolecules . 2021;11(2):203. doi:10.3390/biom11020203 33540574
   PubMed Web of Science ®Google Scholar
• Yin YZ , Yao SH , Li CG , et al. Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma. Am J Transl Res . 2021;13(1):168–182.33527016
   PubMed Web of Science ®Google Scholar
• Madden SK , de Araujo AD , Gerhardt M , et al. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer . 2021;20(1):3. doi:10.1186/s12943-020-01291-6 33397405
   PubMed Web of Science ®Google Scholar
• Zhao B , Wang Y , Tan X , et al. Inflammatory Micro- environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis. Mol Ther Oncolytics . 2019;15:79–90. doi:10.1016/j.omto.2019.08.009 31650028
   PubMed Web of Science ®Google Scholar
• Wang X , Liang C , Yao X , et al. PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF- Mediated PD-L1 Transcription in HCC. Front Pharmacol . 2020;11:577108. doi:10.3389/fphar.2020.577108 33324209
   PubMed Web of Science ®Google Scholar
• Song J , Liu Y , Liu F , et al. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway. Theranostics . 2021;11(3):996–1015. doi:10.7150/thno.51646 33391517
   PubMed Web of Science ®Google Scholar
• Lin Z , Huang W , He Q , et al. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter. J Exp Clin Cancer Res . 2021;40(1):50. doi:10.1186/s13046-021-01829-6 33522955
   PubMed Web of Science ®Google Scholar
• Li J , Zhuo JY , Zhou W , et al. Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway. Am J Transl Res . 2020;12(6):2875–2889.32655816
   PubMed Web of Science ®Google Scholar
• Du K , Li Y , Liu J , et al. A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC. Mol Ther . 2021;29(4):1572–1584. doi:10.1016/j.ymthe.2021.01.006 33429083
   PubMed Web of Science ®Google Scholar
• Ding B , Fan W , Lou W . hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis. Mol Ther Nucleic Acids . 2020;22:445–455. doi:10.1016/j.omtn.2020.09.007 33230448
   PubMedGoogle Scholar
• Wang B , Zhao L , Fish M , et al. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature . 2015;524(7564):180–185. doi:10.1038/nature14863 26245375
   PubMed Web of Science ®Google Scholar
• Lüdtke TH , Christoffels VM , Petry M , et al. Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology . 2009;49(3):969–978. doi:10.1002/hep.22700 19140222
   PubMed Web of Science ®Google Scholar
• Suzuki A , Sekiya S , Büscher D , et al. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development . 2008;135(9):1589–1595. doi:10.1242/dev.016634 18356246
   PubMed Web of Science ®Google Scholar
• Zhao Y , Zhou X , He Y , et al. SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion. Oncol Lett . 2018;16(4):4977–4983. doi:10.3892/ol.2018.9273 30250563
   PubMed Web of Science ®Google Scholar
• Chen C , Cai Z , Zhuo Y , et al. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer. BMC Cancer . 2020;20(1):289. doi:10.1186/s12885-020-06776-7 32252682
   PubMed Web of Science ®Google Scholar
• Narayanapillai SC , Han YH , Song JM , et al. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation- associated lung tumorigenesis. Carcinogenesis . 2020;41(11):1518–1528. doi:10.1093/carcin/bgaa059 32602900
   PubMed Web of Science ®Google Scholar
• Pan YC , Nishikawa T , Chang CY , et al. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Mol Ther Oncolytics . 2020;20:175–186. doi:10.1016/j.omto.2020.12.011 33575480
   PubMed Web of Science ®Google Scholar
• Chen XJ , Yuan SQ , Duan JL , et al. The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: a Systematic Review and Meta-Analysis. Dis Markers . 2020;2020:6717912. doi:10.1155/2020/6717912 33488843
   PubMed Web of Science ®Google Scholar
• Chen J , Sun HW , Yang YY , et al. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduct Target Ther . 2021;6(1):4. doi:10.1038/s41392-020-00377-3 33414378
   PubMed Web of Science ®Google Scholar
• Yuan Y , Wang L , Ge D , et al. Exosomal O-GlcNAc transferase from esophageal carcinoma stem cell promotes cancer immunosuppression through up-regulation of PD-1 in CD8+ T cells. Cancer Lett . 2021;500:98–106. doi:10.1016/j.canlet.2020.12.012 33307156
   PubMed Web of Science ®Google Scholar
• Del Re M , van Schaik RHN , Fogli S , et al. Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: applications for optimal use of anti-PD-1/PD-L1 axis inhibitors. Biochim Biophys Acta Rev Cancer . 2021;1875(1):188463. doi:10.1016/j.bbcan.2020.188463 33137405
   PubMed Web of Science ®Google Scholar
• Yao Q , Gu L , Su R , et al. Efficacy and safety of combination PD-1/PD-L1 checkpoint inhibitors for malignant solid tumours: a systematic review. J Cell Mol Med . 2020;24(22):13494–13506. doi:10.1111/jcmm.15991 33078904
   PubMed Web of Science ®Google Scholar
• Liu Z , Wang J , Liu L , et al. Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice. Theranostics . 2020;10(20):9249–9267. doi:10.7150/thno.46005 32802190
   PubMed Web of Science ®Google Scholar
• Zhang X , Ouyang X , Xu Z , et al. CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39. Mol Ther . 2019;27(11):1963–1973. doi:10.1016/j.ymthe.2019.07.014 31402273
   PubMed Web of Science ®Google Scholar
• Miao Z , Chen L , Feng H , et al. Baitouweng Decoction Ameliorates Ulcerative Colitis in Mice Partially Attributed to Regulating Th17/Treg Balance and Restoring Intestinal Epithelial Barrier. Front Pharmacol . 2021;11:531117. doi:10.3389/fphar.2020.531117 33597862
   PubMed Web of Science ®Google Scholar
• Covre LP , De Maeyer RPH , Gomes DCO , et al. The role of senescent T cells in immunopathology. Aging Cell . 2020:e13272. doi:10.1111/acel.13272 33166035
   PubMed Web of Science ®Google Scholar
• Shen C , Xu T , Sun Y , et al. Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer. Dis Markers . 2020;2020:8866730. doi:10.1155/2020/8866730 33456631
   PubMed Web of Science ®Google Scholar
• Wang Z , Guo X , Gao L , et al. Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies. Mol Ther Oncolytics . 2020;20:34–47. doi:10.1016/j.omto.2020.12.012 33575469
   PubMed Web of Science ®Google Scholar
• Luo YT , Liang YF , He H , et al. The immunosuppressant fingolimod ameliorates experimental autoimmune myasthenia gravis by regulating T-cell balance and cytokine secretion. Am J Transl Res . 2020;12(6):2600–2613.32655793
   PubMed Web of Science ®Google Scholar